ÖGPath Herbsttagung 2023

Are you finding it challenging to get started with genomic testing strategies? Are you completely new to NGS data interpretation? Interested in learning from other professionals who are willing to share their experience in molecular profiling? Are you looking to learn through self-study with guided tutorials?
We think professionals working in precision medicine want to: 

• improve how they approach solving problems that they face in their role
• collaborate more effectively with another function within their institution
• build a network of professionals tackling similar problems

Below you can find some highlights from the Vessel platform to get you started.

Bringing Comprehensive Genomic Profiling to Greek Pathology

We worked together with a small group of pathologists from Greece seeking to implement CGP in their labs. Here, you can access our pilot program that covers concepts like tissue acquisition/QC, sequencing strategies, and introductions to bioinformatics, variant interpretation and clinical decision support.

To access this program, you need to register first - it's free.

Bringing CGP to Greek Pathology

Trusted genomic profiling advisory.

VesselSamantha Hasenleithner

Variant Interpretation

Variant interpretation of molecular findings is a complex process. Here, Prof. Ellen Heitzer of the Institute of Human Genetics at the Medical University of Graz provides a high-level overview of what is needed to interpret molecular findings. Check out the post and video below.

An overview of NGS data interpretation for clinical reporting

Trusted genomic profiling advisory.

VesselDieter Hasenleithner

In another effort to break down the interpretation workflow, we have begun a series of briefings so that you can become more familiar with the necessary resources & know-how to perform this analysis. Below is the first session of more to come!

VB04 - Let’s interpret some variants

In this briefing, we walk you through a step-by-step process of the resources you can access to assess variant pathogenicity and actionability.

VesselSamantha Hasenleithner

Liquid Biopsy

For those new to liquid biopsy and interpreting associated findings, here we have compiled a series of tutorials for you to get started: an overview of testing strategies, how to calculate tumor fraction and other case studies.

www.vesseldna.com/navigating-the-clinical-ctdna-testing-landscape/

Estimating tumor fraction from plasma cell-free DNA

Vessel Tutorial - Understanding liquid biopsy results is highly dependent on tumor fraction of the cell-free DNA sample. Without information about ctDNA content from plasma, variant allele frequencies and uninformative testing results are very difficult to interpret.

VesselSamantha Hasenleithner

VB01 - Two CGP case studies from liquid biopsy

Vessel Briefings are short sessions that are intended to not take too much time out of your busy schedule, but that still allow our community to interact on important topics.

VesselDieter Hasenleithner

VB02 - Concordance of genomic results between tissue and liquid testing

Tissue and circulating tumor DNA testing can detect cancer alterations, but discrepancies in results can impact treatment decisions. This briefing discusses the basics and presents case studies.

VesselDieter Hasenleithner

ctDNA profiling case studies

In this condensed tutorial, Vessel presents three real-world cases of patients with confirmed progressive disease in which liquid biopsy was used to identify actionable targets. The tutorial also includes a brief summary of the patient’s history and the results of the liquid biopsy.

VesselSamantha Hasenleithner

Preceptorship program

Our first ever preceptorship will begin in March 2024. Do you want to learn more about this opportunity or know someone who would benefit from this hands-on, personalized training? Get in contact with us below to learn more.

What Vessel is all about

The Vessel initiative is working on establishing a community coupled with career programs to bridge the gap between precision medicine and its clinical application. There is an information overload in the field, especially when it comes to next-generation sequencing, and we want to make genomics-guided medicine more accessible to those who need to work with it. We provide how-to guidance to solving specific problems for those who work with molecular medicine. It's our job to enable professionals to create impact at their workplace to accelerate precision oncology’s reach. We highly value your willingness to participate and contribute to this initiative.

Proven frameworks

We work with leading companies as well as leaders at companies and institutions, identifying patterns how to create value, produce impact and implement novel solutions to improving precision oncology.

Transfer of experience and problem-solving skills

Some journeys can't be walked alone. Mentoring is non-optional in the intersection of multiple knowledge domains.

Vetted expert network

We're serious about moving the needle when it comes to implementing precision oncology approaches in the clinic. Vessel membership is by application only, for precision medicine-related roles only.

Coming up - The Molecular Tumor Board Essentials (Q1 2024)

Many of our members have expressed interest in getting to know the ins and outs of molecular tumor boards: the need, the infrastructure, the implementation and the results. We are putting together such a program to address these topics, which will be launched early next year. You can stay in the loop by signing up.